Literature DB >> 9490237

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.

K Robinson1, K Arheart, H Refsum, L Brattström, G Boers, P Ueland, P Rubba, R Palma-Reis, R Meleady, L Daly, J Witteman, I Graham.   

Abstract

BACKGROUND: A high plasma homocysteine concentration is a risk factor for atherosclerosis, and circulating concentrations of homocysteine are related to levels of folate and vitamin B6. This study was performed to explore the interrelationships between homocysteine, B vitamins, and vascular diseases and to evaluate the role of these vitamins as risk factors for atherosclerosis.
METHODS: In a multicenter case-control study in Europe, 750 patients with documented vascular disease and 800 control subjects frequency-matched for age and sex were compared. Plasma levels of total homocysteine (before and after methionine loading) were determined, as were those of red cell folate, vitamin B12, and vitamin B6.
RESULTS: In a conditional logistic regression model, homocysteine concentrations greater than the 80th percentile for control subjects either fasting (12.1 micromol/L) or after a methionine load (38.0 micromol/L) were associated with an elevated risk of vascular disease independent of all traditional risk factors. In addition, concentrations of red cell folate below the lowest 10th percentile (<513 nmol/L) and concentrations of vitamin B6 below the lowest 20th percentile (<23.3 nmol/L) for control subjects were also associated with increased risk. This risk was independent of conventional risk factors and for folate was explained in part by increased homocysteine levels. In contrast, the relationship between vitamin B6 and atherosclerosis was independent of homocysteine levels both before and after methionine loading.
CONCLUSIONS: Lower levels of folate and vitamin B6 confer an increased risk of atherosclerosis. Clinical trials are now required to evaluate the effect of treatment with these vitamins in the primary and secondary prevention of vascular diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490237     DOI: 10.1161/01.cir.97.5.437

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  72 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 2.  Treatment of atherosclerotic disease at the cervical carotid bifurcation: current status and review of the literature.

Authors:  J J Connors; D Seidenwurm; J C Wojak; R W Hurst; M E Jensen; R Wallace; T Tomsick; J Barr; C Kerber; E Russell; G M Nesbit; A J Fox; F Y Tsai
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

3.  Cancer prevention and diet: help from single nucleotide polymorphisms.

Authors:  B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 4.  Mediterranean diets and cardiovascular disease.

Authors:  T A Barringer
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

Review 5.  Evidence based cardiology: emerging approaches in preventing cardiovascular disease.

Authors:  E M Lonn; S Yusuf
Journal:  BMJ       Date:  1999-05-15

Review 6.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 7.  Homocysteine and risk of cardiovascular disease.

Authors:  F Andreotti; F Burzotta; A Manzoli; K Robinson
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

8.  The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats.

Authors:  E Nissinen; H Nissinen; H Larjonmaa; A Väänänen; T Helkamaa; I Reenilä; P Rauhala
Journal:  J Neural Transm (Vienna)       Date:  2004-12-22       Impact factor: 3.575

9.  Clinical Evidence: Emerging approaches in preventing cardiovascular disease.

Authors:  E M Lonn; S Yusuf
Journal:  West J Med       Date:  1999-10

10.  Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women.

Authors:  Yvonne Lamers; Bruce O'Rourke; Lesa R Gilbert; Christine Keeling; Dwight E Matthews; Peter W Stacpoole; Jesse F Gregory
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.